Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is O  [Clear All Filters]
2024
Cong M, Ai S, Kang L, Jin M, Zhu Y, Li C, Jin Z, Yu L, Wu D, Huang H. Outcomes of allogeneic hematopoietic stem cell transplantation in R/R DLBCL patients with failure of CAR-T therapy. Exp Hematol Oncol. 2024;13(1):4.
Thanh LNguyen, Le HThu, Nguyen QThi, Van Ngo D, Hoang DGia, Nguyen P-AThi, Bui V-A, Dam PTM. Outcomes of cell infusion for the treatment of neurological sequelae induced by spinal anesthesia-associated subdural hematoma: A case report. Heliyon. 2024;10(4):e25920.
Onozawa M, Kusumoto S, Najima Y, Hashimoto H, Okada K, Tamaki M, Tanaka M, Sato T, Takahashi T, Hatano K, et al. Outcomes of cessation of the administration of nucleos(t)ide analogues on HBV reactivation after allogeneic hematopoietic stem cell transplantation: A nationwide retrospective study. Transplant Cell Ther. 2024.
Shi Z, Gao F, Ding D, Wu H, Shi J, Luo Y, Yu J, Tan Y, Lai X, Liu L, et al. Outcomes of haploidentical peripheral blood stem cell transplantation following myeloablative conditioning using two types of rabbit ATG: a propensity score-matched analysis. Ann Hematol. 2024.
Gregory K, Hansen D, Penglase R, Apostolopoulos D, Ngian G-S, Stevens W, Morrisroe K, Ferdowsi N, Ross L, Walker J, et al. Outcomes of patients with diffuse systemic sclerosis eligible for autologous stem cell transplantation managed with conventional therapy. Arthritis Rheumatol. 2024.
Pasvolsky O, Ghanem S, Milton DR, Rauf M, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, et al. Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience. Blood Cancer J. 2024;14(1):4.
Jain N, Mittal V, Sanandiya D. Outcomes of Simple Limbal Epithelial Transplantation Without Amniotic Membrane Grafting in Unilateral Limbal Stem Cell Deficiency: A Case Series of 6 Patients. Cornea. 2024.
Malek AE, Al-Juhaishi T, Milton DR, Ramdial JL, Daher M, Olson AL, Srour SA, Alatrash G, Oran B, Mehta RS, et al. Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis. Bone Marrow Transplant. 2024.
Cohen J, Shah S, Piedra K, Shalhoub S, Benjamin C, Pereira D. Outcomes of upfront plerixafor use for mobilization in germ cell tumor patients. Hematol Transfus Cell Ther. 2024.
Shahzad M, Iqbal Q, Tariq E, Ammad-Ud-Din M, Butt A, Mushtaq AHassan, Ali F, Chaudhary SGull, Anwar I, Gonzalez-Lugo JD, et al. Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in TP53-mutated Myelodysplastic syndrome: A Systematic Review and Meta-Analysis. Crit Rev Oncol Hematol. 2024:104310.
Mushtaq MUmair, Shahzad M, Amin MK, Lutfi F, DeJarnette S, Al-Ramahi JS, Li K, Ahmed N, Bansal R, Abdelhakim H, et al. Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation. Leuk Lymphoma. 2024:1-10.
Li X, Lin Y, Cheng X, Yao G, Yao J, Hu S, Zhu Q, Wang Y, Ding Y, Lu Y, et al. Ovarian ferroptosis induced by androgen is involved in pathogenesis of PCOS. Hum Reprod Open. 2024;2024(2):hoae013.
Sahoo D, Dey A, Dash A, Dash A. Ovarian mass Presenting as Paraneoplastic cerebellar degeneration with peripheral neuropathy and anti-Yo antibody. BMJ Case Rep. 2024;17(1).
Missontsa MMillin, Bernaudin F, Fortin A, Dhedin N, Pondarré C, Yakouben K, Neven B, Castelle M, Cavazzana M, Lezeau H, et al. Ovarian tissue cryopreservation for fertility preservation before hematopoietic stem cell transplantation in patients with sickle cell disease: safety, ovarian function follow-up, and results of ovarian tissue transplantation. J Assist Reprod Genet. 2024.
Soykan MNur, Gunes S. Overexpression of Klotho gene using CRISPR/Cas9 induces apoptosis and inhibits cell motility in the human colorectal cancer cells. Biotechnol J. 2024;19(2):e2300496.
Zhang X, Du W, Huang X, Zhong H, Hu N. An overview of current research on cancer stem cells: a bibliometric analysis. Clin Transl Oncol. 2024.
Abduh MSiddiq. An overview of multiple myeloma: A monoclonal plasma cell malignancy's diagnosis, management, and treatment modalities. Saudi J Biol Sci. 2024;31(2):103920.
Shirkoohi FJamali, Ghollasi M, Halabian R, Eftekhari E, Ghiasi M. Oxaloacetate as new inducer for osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells in vitro. Mol Biol Rep. 2024;51(1):451.
Sun L, Jin Y, Nishio M, Watanabe M, Kamakura T, Nagata S, Fukuda M, Maekawa H, Kawai S, Yamamoto T, et al. Oxidative phosphorylation is a pivotal therapeutic target of fibrodysplasia ossificans progressiva. Life Sci Alliance. 2024;7(5).
Jara-Gutiérrez C, Mercado L, Paz-Araos M, Howard C, Parraga M, Escobar C, Mellado M, Madrid A, Montenegro I, Santana P, et al. Oxidative stress promotes cytotoxicity in human cancer cell lines exposed to Escallonia spp. extracts. BMC Complement Med Ther. 2024;24(1):38.
Guan T, Guo Y, Zhou T, Yu Q, Sun J, Sun B, Zhang G, Kong J. Oxidized SOD1 accelerates cellular senescence in neural stem cells. Stem Cell Res Ther. 2024;15(1):55.
2023
Yue B, Lin L, Lei Y, Xie H, Si Y, Yang Q, Liu X. O, N Coordination-Mediated Nickel Single-Atom Catalysts for High-Efficiency Generation of HO. ACS Appl Mater Interfaces. 2023.
Kim H-S, Ha H-S, Kim D-H, Son DHyeon, Baek S, Park J, Lee CHee, Park S, Yoon H-J, Yu SEun, et al. O variant chip to simulate site-specific skeletogenesis from hypoxic bone marrow. Sci Adv. 2023;9(12):eadd4210.
Wallner E-S, Tonn N, Shi D, Luzzietti L, Wanke F, Hunziker P, Xu Y, Jung I, Lopéz-Salmerón V, Gebert M, et al. OBERON3 and SUPPRESSOR OF MAX2 1-LIKE proteins form a regulatory module driving phloem development. Nat Commun. 2023;14(1):2128.
Glasstetter LM, Oderinde TS, Mirchandani M, Rajagopalan KSankaran, Barsom SH, Thaler R, Siddiqi S, Zhu X-Y, Tang H, Jordan KL, et al. Obesity and dyslipidemia are associated with partially reversible modifications to DNA hydroxymethylation of apoptosis- and senescence-related genes in swine adipose-derived mesenchymal stem/stromal cells. Stem Cell Res Ther. 2023;14(1):143.

Pages